Cognition Therapeutics - Company Profile - Tracxn

Nov 5, 2024  · Cognition Therapeutics ranks 25th among 424 active competitors. 149 of its competitors are funded while 74 have exited. Overall, Cognition Therapeutics and its …


Install CouponFollow Chrome Extension   CouponFollow Extension

$36
OFF

Cognition Therapeutics - Company Profile - Tracxn

1 week from now

Cognition Therapeutics - Developer of small molecule drugs for neurodegenerative diseases. Public Company. Raised a total funding of $36.1M over 14 rounds from 28 investors. Founded …

tracxn.com

$36
OFF

Cognition Therapeutics Funding & Investors - Tracxn

1 week from now

Aug 24, 2024  · Cognition Therapeutics has raised a total funding of $36.1M over 14 rounds from 28 investors. Investors include NIH, Tech Coast Angels and 26 others. Their latest funding …

tracxn.com

$36
OFF

Cognition Therapeutics - Raised $36.1M Funding From 28 …

1 week from now

Cognition Therapeutics has raised a total funding of $36.1M over 14 rounds from 28 investors. Investors include Tech Coast Angels, The Michael J. Fox Foundation and 26 others. Their …

tracxn.com

$21
OFF

Cognition - Company Profile - Tracxn

1 week from now

Cognition - Provider of low code developement platform for AI application. Raised a total funding of $21M over 1 round from 6 investors. Founded by Scott Wu and Steven Hao in the year …

tracxn.com

$196
OFF

Cognition - Company Profile - Tracxn

1 week from now

Nov 5, 2024  · Barbarella Hair - Northampton based, 2011 founded, Unfunded company. Cognition - AI powered coding assistants for developers. Raised a total funding of $196M over 2 rounds …

tracxn.com

FAQs about Cognition Therapeutics - Company Profile - Tracxn Coupon?

How many investors does cognition therapeutics have?

Cognition Therapeutics has 17 investors including National Institute on Aging and National Institute on Aging. How much funding has Cognition Therapeutics raised to date? Cognition Therapeutics has raised . When was the last funding round for Cognition Therapeutics? ...

Where is cognition Therapeutics located?

Cognition Therapeutics is located in Pittsburgh, Pennsylvania, United States. Who invested in Cognition Therapeutics? Cognition Therapeutics has 17 investors including National Institute on Aging and National Institute on Aging. How much funding has Cognition Therapeutics raised to date? Cognition Therapeutics has raised . ...

When did cognition Therapeutics close?

Cognition Therapeutics closed its last funding round on Nov 15, 2022 from a Post-IPO Equity round. Who are Cognition Therapeutics 's competitors? Alternatives and possible competitors to Cognition Therapeutics may include Excision BioTherapeutics , Interius BioTherapeutics , and Tmunity Therapeutics. ...

What does cognition Therapeutics do?

Cognition Therapeutics, Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of disease targets, and there are ...

What did cognition Therapeutics (CGTX) do in the third quarter 2024?

PURCHASE, N.Y., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, (the “Company” or “Cognition”) today reported financial results for the third quarter ended September 30, 2024, and provided a business update. ...

What is cognition Therapeutics ct1812?

CT1812, Cognition Therapeutics’ lead product candidate is a once-daily, oral, small-molecule designed to rescue trafficking deficits, a “housekeeping” function that is impaired in neurodegenerative and neuro-ophthalmic diseases. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension